Caribou Biosciences, Inc. (CRBU) vs Foghorn Therapeutics Inc. (FHTX)
A side-by-side comparison of Caribou Biosciences, Inc. and Foghorn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBU
Caribou Biosciences, Inc.
$1.19HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
FHTX
Foghorn Therapeutics Inc.
$2.01HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — CRBU vs FHTX
growth of $100 · dividends reinvested · last 5yCRBU -92.7% (-40.8%/yr)FHTX -79.3% (-27.0%/yr)FHTX compounded faster over this window
CRBU FHTX
CRBU vs FHTX: by the numbers
- •FHTX is the larger company ($118M vs $118M market cap).
- •Both run net losses; FHTX's is the smaller (-175.78% vs -1030.42% net margin).
- •FHTX grew revenue faster over the past five years (105.83% vs -2.03% CAGR).
Metrics side by side
Valuation
| Metric | CRBU | FHTX |
|---|---|---|
| P/S ratio | 11.71 | 3.21 |
| P/B ratio | 1.20 | N/A |
Profitability
| Metric | CRBU | FHTX |
|---|---|---|
| Gross margin | 67.34% | 89.22% |
| Operating margin | -1220.49% | -265.64% |
| Net margin | -1030.42% | -175.78% |
| ROE | -105.40% | N/A |
| ROIC | -87.72% | -44.81% |
Growth (annualized)
| Metric | CRBU | FHTX |
|---|---|---|
| Revenue CAGR (5Y) | -2.03% | 105.83% |
| Total return CAGR (5Y) | -44.43% | -31.87% |
Frequently asked
- Which has grown faster, CRBU or FHTX?
- Over the past five years, FHTX grew revenue faster — CRBU at a -2.03% CAGR versus FHTX at 105.83%.
- How have CRBU and FHTX total returns compared?
- Over the past 5 years, CRBU delivered -44.43% and FHTX delivered -31.87% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Caribou Biosciences ROEFoghorn Therapeutics ROECaribou Biosciences operating marginFoghorn Therapeutics operating marginCaribou Biosciences revenue growthFoghorn Therapeutics revenue growthCaribou Biosciences free cash flowFoghorn Therapeutics free cash flow
Caribou Biosciences & Foghorn Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.